Targeting metabolic fluxes reverts metastatic transitions in ovarian cancer
Garhima Arora, Mallar Banerjee, Jimpi Langthasa, Ramray Bhat, Samrat Chatterjee
The paper identifies metabolic reaction modules driving metastatic transitions in ovarian cancer and validates oseltamivir as a non-cytotoxic drug to disrupt spheroidal morphologies.
iScience · Sep 28, 2023Peer-reviewedSystems Biology